Quantcast

Burgeoning nutraceuticals industry could boost pharmacy cashflow

0

As the pressure to deliver mounts on local pharmacies, the burgeoning nutraceuticals industry could help ease the strain that is being caused by a number of industry issues.  Many pharmacies are currently dispensing prescription medication at a loss in real terms due to the nature of the NHS prescription payment system.

Further to this, the amount that pharmacies are reimbursed for issuing   prescribed medication  to customers has decreased over the years. Hence pharmacists are having to work harder year on year in order to try and maintain a steady income.

Figures from the Pharmaceutical Services Negotiating Committee (PSNC) show that the number of concessions granted to pharmacies in the UK decreased from 86 in December 2017 to 80 in January 2019. The Committee also noticed a surge in the number of prescribed generic medications that are unavailable to be purchased at Drug Tariff price or even at the concessionary prices further adding to the strains on cash flow in most pharmacies

However, clinically validated nutraceuticals could help rescue pharmacies who are experiencing dwindling cashflow. The global vitamins, minerals and supplements (VMS) market is set to grow to $278.02 billion by 2024 and by stocking and providing a range of clinically validated nutraceutical supplements, pharmacies can improve their cashflow. This in turn will assist pharmacies in re-establishing themselves as go-to community health advisers

The ‘Help Us, Help You Pharmacy Advice Campaign’, launched by the NHS in February this year, is placing pharmacies at the forefront of the drive for promoting self-care in local communities. London-based nutraceutical company MedTate believes that pharmacies have a big part to play in ensuring the wellness and health of their local communities. While consumer behaviour has changed in recent years, pharmacists are still being relied upon by their communities to deliver vital medication as well as advice on prevention and treatments in all matters of health and wellness.

The potential for pharmacists to drive positive change in people’s health is exciting and challenging but truth be told no one is better placed to deliver health and wellness advice in local communities than pharmacists. This has been further supported by the recent campaign from the NHS which fundamentally encourages pharmacists to offer prevention in the form of wellness advice and not just the treatment in the form of medication. Clinically validated nutraceuticals available over the counter (OTC) are key in delivering this self-help.

MedTate enables pharmacies to make available  its clinically validated Ojamin Herb & Fruit supplement to people who are suffering with type 2 diabetes and those who are seeking an impactful health supplement.

MedTate also believes in providing pharmacists and their staff excellent educational and training material which is being put together with the assistance of part-time GP and TV doctor, Dr Hilary Jones, who will also help develop the patient and consumer educational portal for MedTate.

Hiten Parekh, head of business development at the Total Body Care (Orbis & Pearl Pharmacy in Clapham) said, “We are able to promote natural products to our community and neighbouring areas as we are finding more people are interested in taking supplements alongside any medication. For those who don’t take prescribed medication, Ojamin could assist in the potential prevention of diabetes and weight management. We have had brilliant feedback and frequent regular buyers at our pharmacies and online.

“These are hard times for retail across the board and we have noticed that there is a slight rise in nutraceutical products, and we are confident that this will be a large part of our sales in the near future.  We are definitely having more walk-ins for nutraceuticals and the natural health market is growing.”

Existing pharma companies generally try to monetise their research and development (R&D) in drug development by launching their products as drugs first at high prices and then, only after their patent has expired, do they consider delivering into the OTC market.

However, MedTate’s disruptive model ensures that independent clinically validated products go straight to the OTC market first via the pharmacies. This enables pharmacists to take advantage of ground-breaking treatments in supplement form as soon as possible and offer them as supplements to their customer base. MedTate’s solid two-pronged approach encompasses both R&D and OTC products and ensures the company can introduce clinically validated breakthrough products to market while simultaneously researching and developing these same products into potential prescription medicines.

Pete Tate, CEO and founder of MedTate said, “Pharmacies are essential in reviving high streets across the country and they need to show how effective they can be in kick-starting positive changes in people’s health by becoming champions of health and wellness. MedTate’s disruptive model and breakthrough products enables them to deliver innovative products to patients and encourage them to advise people on overall wellness.”

As well as being sold in Selfridges and John Bell & Croyden, Ojamin is primarily available through independent pharmacies only. With its ground-breaking product Ojamin, Medtate will no doubt have a positive effect for those pharmacies who stock it by increasing footfall and customer spend as the MedTate marketing campaign takes shape. This extra cash will no doubt help ease some of the burden caused by the NHS payment system




Share.